PUBLISHED LOT DOCUMENTATION
Ipamorelin
LOT IPL5A
Tested Aug 12, 2026 · Certificate COA-2026-CHFAHT
This laboratory documentation does not indicate product availability or commercial release.
- Product
- Ipamorelin
- ILS lot number
- IPL5A
- Document type
- ILS laboratory certificate
- Testing laboratory
- ILS Laboratories
- Test date
- Aug 12, 2026
- Laboratory result
- PASS
- Reported HPLC purity (per ILS)
- 99.80%
- Laboratory certificate
- COA-2026-CHFAHT
- Peptide Purity (HPLC) method
- RP-HPLC area normalization at 214 nm
- Net Peptide Content
- 5.32 mg N/A
- Identity (ID)
- Confirmed PASS
- Identity (ID) method
- HPLC. Identification by chromatographic retention time comparison with a reference standard.
- Arsenic (As)
- 0.37 ppm PASS
- Arsenic (As) method
- ICP-MS per USP ⟨233⟩ methodology
- Cadmium (Cd)
- 0.434 ppm PASS
- Cadmium (Cd) method
- ICP-MS per USP ⟨233⟩ methodology
- Chromium (Cr)
- 0.564 ppm PASS
- Chromium (Cr) method
- ICP-MS per USP ⟨233⟩ methodology
- Mercury (Hg)
- 0.634 ppm PASS
- Mercury (Hg) method
- ICP-MS per USP ⟨233⟩ methodology
- Lead (Pb)
- 0.518 ppm PASS
- Lead (Pb) method
- ICP-MS per USP ⟨233⟩ methodology
- Sterility (PCR)
- No Growth PASS
- Sterility (PCR) method
- PCR (Polymerase Chain Reaction) method
- Endotoxin (USP <85>)
- 0.028 EU/mL Reported
- Endotoxin (USP <85>) method
- USP ⟨85⟩ kinetic chromogenic method
- Fentanyl Screen
- Confirmed Fentanyl Free
Integrity details
Ohana's archived copy was recorded on September 8, 2026.
This SHA-256 value identifies the exact archived PDF file.
da564e67243964cfb1abb6df57903e8659e60a1856a18a9513b2b6859abfce69
